End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.742 USD | -7.52% | -20.22% | -97.27% |
May. 21 | Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M | MT |
May. 20 | Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Sunshine Biopharma, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Sunshine Biopharma, Inc.
Aegis Capital |
EPS Revisions
- Stock Market
- Equities
- SBFM Stock
- Consensus Sunshine Biopharma, Inc.